|
Each
DSP provides:
- Complete understanding of the disease dynamics
- Treatment algorithms (based on longitudinal data)
- Market definition, labelling, sizing, structure and segmentation
- Key drivers for drug therapy
- Unmet needs and disease impact
- Detailed prescribing patterns (including dosage analysis, switching patterns, combination therapy).
- Monitoring brand positioning and performance
- Brand mapping
- Identification of market trends and changes
- Impact of medico-marketing strategies
- Health outcomes.
Markets covered include: Europe, USA, Canada, Japan, China, Latin America and Australia.
Outputs from DSPs are increasingly being used in scientific publications, abstracts, posters, regulatory submissions and detail aids across a number of disease areas to support brand development.
DSP information is also routinely incorporated into health economic and patient-reported outcomes models such as cost of illness and quality of life.

Outcomes
Solutions
Real world observational data substantiating opportunities
and challenges for brands:
- PROs
- Quality of life
- Patient satisfaction
- Burden of disease
- Resource utilisation
- Longitudinal perspectives

Communications
Solutions
The industry gold standard for shaping marketing and communication strategy and defining education imperatives
- Tailored consultation and creative input to communications strategy development
- Creative support to key planning meetings
- A statistical service that responds rapidly with expert knowledge of the data
- A writing and publication management service - to secure timely publication
- A creative team delivering campaigns designed to maximise the impact of opinion-changing publications

|
|
Areas of Expertise
Disease
and Market Understanding
Observational Research
Office Location(s)
Adelphi
Mill, UK
New
York, USA
Established
1995
Managing
Director
Maria
Karavali
|
|
 |
 |
| Disease understanding,
impact and brand development |
|
 |
|